This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Price-gouging violation depends on product ‘essentiality,’ market regulation, CADE's top investigator says

By Ana Paula Candil and Flavia Fortes ( July 27, 2020, 12:00 GMT | Insight) -- Charging exorbitant prices in times of emergency is an antitrust violation when the product is essential, the market is a near-monopoly and when regulation can't solve the problem with abusive increased prices, the Brazilian competition authority's top investigator told MLex, referring to the agency’s probe of alleged price-gouging involving medical and pharmaceutical products. Charging exorbitant prices in times of emergency is an antitrust violation when the product is essential, the market is a near-monopoly and when regulation can't solve the problem with abusive increased prices, the Brazilian competition authority's top investigator, Alexandre Cordeiro, told MLex, referring to the agency’s investigation into alleged price-gouging involving medical and pharmaceutical products....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections